Interventional cardiology in a whole new light

Open menu

News & Events

OPSENS: HEALTH CANADA APPROVAL FOR THE SALE OF OPTOWIRE II

22 June 2016

Quebec City, Quebec, June 22, 2016 – Opsens Inc. (“Opsens” or the “Company”) (TSXV:OPS) (OTCQX:OPSSF) today announced receipt of Health Canada approval to sell the OptoWire II in Canada. The OptoWire II is an optical guidewire developed to measure Fractional Flow Reserve (“FFR“). FFR measurement is used for the diagnostic of the severity of coronary…

Read more